- Essential tremor
- Gait abnormality
- Huntington's disease
- Movement disorder
- Parkinson's disease
- Tremor
Stephen Aradi, MD
About me
- Assistant Professor of Clinical Neurology
My education and training
- Medical School: University of South Florida College of Medicine
- Residency: Hospital of the University of Pennsylvania
- Fellowship: University of South Florida College of Medicine
Spoken languages
Insurance accepted
- Aetna Advantra Cares D-SNP
- Aetna Advantra Credit Value
- Aetna Advantra Eagle HMO
- Aetna Advantra Eagle POS
- Aetna Advantra Premier Plus PPO
- Aetna Advantra Value
- Aetna Advantra Value Plus
- Aetna APCN Plus (Multi-Tier)
- Aetna Better Health Kids (CHIP) - DH Only
- Aetna Flexible Five
- Aetna Freedom Core
- Aetna Gold
- Aetna HMO
- Aetna Philly Prime
- Aetna POS
- Aetna PPO APCN
- Aetna Premier
- Aetna Premier Plus
- Aetna Savings Plus
- Aetna Signature Administrators
- Aetna Student Health Plan PPO
- Aetna Upfront Advantage
- First Health HMO
- First Health POS
- First Health PPO
- Meritain - Aramark (Other)
- Meritain - Aramark (Pennsylvania Premier Medical Plan)
- Amerihealth of NJ Core
- Amerihealth of NJ Enhanced
- Amerihealth of NJ HMO
- Amerihealth of NJ Local Value
- Amerihealth of NJ POS
- Amerihealth of NJ PPO
- Amerihealth of NJ Regional Preferred
- Amerihealth of NJ Secure
- Amerihealth of NJ Ultimate (PPO)
- Centivo EPO
- Cigna Healthcare EPO
- Cigna Healthcare HMO
- Cigna Healthcare POS
- Cigna Healthcare PPO
- Claim Watcher (Homestead/ INDECs) Open Access
- Clover Health Choice
- Clover Health Choice Value PPO
- Clover Health Classic HMO
- Clover Health Value
Locations
Penn Medicine hospital privileges
- Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
- Pennsylvania Hospital: Has privileges to treat patients in the hospital.
- Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Qualifications and experience
- Neurology
Treatments and conditions
Research
Publications
Vaillancourt DE, Barmpoutis A, Wu SS, DeSimone JC, Schauder M, Chen R, Parrish TB, Wang WE, Molho E, Morgan JC, Simon DK, Scott BL, Rosenthal LS, Gomperts SN, Akhtar RS, Grimes D, De Jesus S, Stover N, Bayram E, Ramirez-Zamora A, Prokop S, Fang R, Slevin JT, Kanel P, Bohnen NI, Tuite P, Aradi S, Strafella AP, Siddiqui MS, Davis AA, Huang X, Ostrem JL, Fernandez H, Litvan I, Hauser RA, Pantelyat A, McFarland NR, Xie T, Okun MS; AIDP Study Group; Leader A, Russell Á, Babcock H, White-Tong K, Hua J, Goodheart AE, Peterec EC, Poon C, Galarce MB, Thompson T, Collier AM, Cromer C, Putra N, Costello R, Yilmaz E, Mercado C, Mercado T, Fessenden A, Wagner R, Spears CC, Caswell JL, Bryants M, Kuzianik K, Ahmed Y, Bendahan N, Njoku JO, Stiebel A, Zahed H, Wang SS, Hoang PT, Seemiller J, Du G Automated Imaging Differentiation for Parkinsonism , JAMA Neurol, 82(5): 2025,495-505
Aradi S, Hauser RA. Current use of neurotoxins for alleviating symptoms of cervical dystonia , Expert Rev Neurother, 24(8): 2024,787-797
Song W, Daneman L, Cohen-Oram A, Aradi S A Case Series of Delusional Infestation in Huntington's Disease , J Huntingtons Dis, 13(3): 2024,399-401
McColgan P, Thobhani A, Boak L, Schobel SA, Nicotra A, Palermo G, Trundell D, Zhou J, Schlegel V, Sanwald Ducray P, Hawellek DJ, Dorn J, Simillion C, Lindemann M, Wheelock V, Durr A, Anderson KE, Long JD, Wild EJ, Landwehrmeyer GB, Leavitt BR, Tabrizi SJ, Doody R Tominersen in Adults with Manifest Huntington's Disease , N Engl J Med, 389(23): 2023 ,2203-2205
Jiang RY, Aradi S. F198S Gerstmann-Sträussler-Scheinker Syndrome With Parkinsonism, Dyskinesia, and Abnormal (I-123)-FP-CIT Single-Photon Emission Computed Tomography: A Case Report , Cureus, 15(12): 2023,e50594
McLean L, Aradi S, Waknin R, Rea B, Camacho MA HIV-associated dementia presenting predominantly with clinical motor deficits: A case report , Radiol Case Rep, 17(9): 2022,3005-3008
Scheid BH, Aradi S, Pierson RM, Baldassano S, Tivon I, Litt B, Gonzalez-Alegre P Predicting Severity of Huntington's Disease With Wearable Sensors , Front Digit Health, 4: 2022,874208
Jenner P, Mori A, Aradi SD, Hauser RA. Istradefylline - a first generation adenosine A2A antagonist for the treatment of Parkinson’s disease , Expert Rev Neurother, 21(3): 2021,317-333
Aradi S, Cucchiara BL Chapter 24: Dysarthria , Decision-Making in Adult Neurology: 2021,48-49
LeWitt PA, Aradi SD, Hauser RA, Rascol O. The challenge of developing adenosine A2A antagonists for Parkinson disease: Istradefylline, preladenant, and tozadenant , Parkinsonism Relat Disord, 80(Suppl 1): 2020,S54-S63